Skip to content

Dynamic Evolution of Pulmonary Nodules and Influence Factors of Its Clinical Decision-making

Dynamic Evolution of Pulmonary Nodules and Influence Factors of Its Clinical Decision-making: A Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04857333
Acronym
DEPICT
Enrollment
1800
Registered
2021-04-23
Start date
2021-01-01
Completion date
2025-12-31
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Nodule, Multiple, Pulmonary Nodule, Solitary

Keywords

Pulmonary nodule, Radiologic picture, Prospective observatory study, Psychological state, Decision-making

Brief summary

The researchers are aimed to investigate the dynamic evolution of indeterminate pulmonary nodules by a long-term follow-up of patients with different characteristics. Influence factors of clinical decision-making that might contribute to overtreatment or delayed treatment will also be studied.

Detailed description

This observatory study prospectively recruits patients with indeterminate pulmonary nodules identified in computed tomography (CT) scans from thoracic clinic. The radiological features and their chronological changes during follow-up period will be recorded in detail. Subgroup analyses will be performed based on the clinical and demographic characteristics of patients (including symptomatic information, comorbidities, family history, antibiotic usage, etc). Hospital Anxiety and Depression Scale (HADS) is collected from each patient at multiple time points to evaluate the patients' psychological status and its impact on clinical decision-making. The interaction analyses between individual characteristics (such as education level, occupation, disease cognitive level, etc) and Hospital Anxiety and Depression Scale will also be performed. The researchers aim to provide high-quality evidence for the formulation of a precise follow-up and management plan for patients with pulmonary nodules.

Interventions

DIAGNOSTIC_TESTCT scan

For patients with low-risk pulmonary nodules, follow-up CT scan is recommended

DRUGAntibiotics

For pulmonary nodules with features of infectious disease, antibiotics is recommended

PROCEDURESurgical Resection

For persistent high-risk pulmonary nodules, surgical resection is recommended

Sponsors

GuiBin Qiao
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients with pulmonary nodules ≤ 3cm 2. Patients who provide electronic, written or oral consent to be enrolled in the follow-up cohort

Exclusion criteria

1. Patients with a surgical history of pulmonary nodules; 2. Patients who have obtained pathological diagnosis through surgery or non-surgical methods such as puncture; 3. Patients with pulmonary nodules that are likely metastatic from other sites; 4. Refuse to participate in this study.

Design outcomes

Primary

MeasureTime frameDescription
Time to surgical resectionThe date of first documented diagnosis of pulmonary nodule by CT scan to the date of surgical resection, up to 60 monthsTime calculated from the date of identification of pulmonary nodule to the date of surgical resection
Time to progressionThe date of first documented diagnosis of pulmonary nodule by CT scan to the date of documented progression by CT scan, up to 60 monthsTime calculated from the date of identification of pulmonary nodule to the date of progression of pulmonary nodule based on evaluation of CT imaging

Secondary

MeasureTime frameDescription
Proportion of malignancyThe date of first documented diagnosis of pulmonary nodule by CT scan to the date of surgical resection, up to 60 monthsProportion of malignant findings by pathological examination in all patients receiving surgical resection
Change of Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scoreThe date of enrollment in our cohort study when Hospital Anxiety and Depression Scale is measured to the date when primary endpoint( surgical resection) is reached, up to 60 months, with multiple measurements.The differences of Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scores of the same patients before and after surgical resection. This 7-item checklist is a part of the Hospital Anxiety and Depression Scale, which is used for assessment for the status of anxiety. The maximal score for HADS-A is 21. Scores of greater than or equal to 11 on either scale indicate a definitive case. Scores of 0-7 are defined to be normal, while scores of 8-10 are defined to be borderline abnormal (borderline case).
Change of Hospital Anxiety and Depression Scale-Depression (HADS-D) scoreThe date of enrollment in our cohort study when Hospital Anxiety and Depression Scale is measured to the date when primary endpoint( surgical resection) is reached, up to 60 months, with multiple measurements.The differences of Hospital Anxiety and Depression Scale-Depression (HADS-D) scores of the same patients before and after surgical resection. This 7-item checklist is a part of the Hospital Anxiety and Depression Scale, which is used for assessment for the status of depression. The maximal score for HADS-D is 21. Scores of greater than or equal to 11 on either scale indicate a definitive case. Scores of 0-7 are defined to be normal, while scores of 8-10 are defined to be borderline abnormal (borderline case).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026